The dopamine-somatostatin chimeric compound BIM-23A760 exerts antiproliferative and cytotoxic effects in human non-functioning pituitary tumors by activating ERK1/2 and p38 pathways
Articolo
Data di Pubblicazione:
2010
Citazione:
The dopamine-somatostatin chimeric compound BIM-23A760 exerts antiproliferative and cytotoxic effects in human non-functioning pituitary tumors by activating ERK1/2 and p38 pathways / E.M. Peverelli, L. Olgiati, M. Locatelli, P. Magni, M.F. Fustini, G. Frank, G. Mantovani, P.L.M. Beck Peccoz, A. Spada, A.G.A. Lania. - In: CANCER LETTERS. - ISSN 0304-3835. - 288:2(2010 Feb), pp. 170-176. [10.1016/j.canlet.2009.06.034]
Abstract:
The study investigated the effects of the dopamine-somatostatin chimeric compound BIM-23A760 on cell proliferation and apoptosis in cultured cells from human non-functioning pituitary tumors (NFPTs). Both BIM-23A760 and the dopaminergic agonist BIM-53097 induced a significant inhibition of cell proliferation associated with increased p27 expression, together with a significant increase in caspase-3 activity. Conversely, null or marginal effects were elicited by somatostatin analogs. Moreover, BIM-23A760 and BIM-53097 induced ERK1/2 and p38 phosphorylation and the blockade of these pathways prevented both the antiproliferative and the pro-apoptotic effects of these drugs. In conclusions the chimeric compound BIM-23A760 is able to exert cytostatic and cytotoxic effects in NFPTs, these phenomena being mainly mediated by DR2D and involving ERK1/2 and p38 pathways activation.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Apoptosis; Cell proliferation; Chimera; Dopamine receptor; Pituitary adenoma; Somatostatin receptor
Elenco autori:
E.M. Peverelli, L. Olgiati, M. Locatelli, P. Magni, M.F. Fustini, G. Frank, G. Mantovani, P.L.M. Beck Peccoz, A. Spada, A.G.A. Lania
Link alla scheda completa: